Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Blood

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Blood|February 15, 2014
SAMHD1: a new gene for CLLDavide Rossi
Blood|February 23, 2019
<i>FBXW7</i> is a biologically validated cancer driver gene for CLLDavide Rossi
Blood|July 13, 2019
Quest of biomarkers for venetoclax-treated CLLDavide Rossi
Blood|March 22, 2014
Lymphocytosis and ibrutinib treatment of CLLDavide Rossi, Gianluca Gaidano
Blood|November 17, 2022
Mechanisms of resistance to venetoclaxAdalgisa Condoluci, Davide Rossi
Blood|March 19, 2016
Splenic marginal zone lymphoma: from genetics to managementLuca Arcaini, Davide Rossi, Marco Paulli
Blood|April 26, 2018
Biology and treatment of Richter syndromeDavide Rossi, Valeria Spina, Gianluca Gaidano
Blood|December 25, 2007
Prognostic assessment of BCL2-938C>A polymorphism in chronic lymphocytic leukemiaDavide Rossi, Silvia Rasi, Daniela Capello, et al.
Blood|February 6, 2010
Impact of the host genetic background on prognosis of chronic lymphocytic leukemiaSilvia Rasi, Francesco Forconi, Alessio Bruscaggin, et al.
Blood|April 26, 2003
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphomaGianluca Gaidano, Laura Pasqualucci, Daniela Capello, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Blood|February 15, 2014
SAMHD1: a new gene for CLLDavide Rossi
Blood|February 23, 2019
<i>FBXW7</i> is a biologically validated cancer driver gene for CLLDavide Rossi
Blood|July 13, 2019
Quest of biomarkers for venetoclax-treated CLLDavide Rossi
Blood|March 22, 2014
Lymphocytosis and ibrutinib treatment of CLLDavide Rossi, Gianluca Gaidano
Blood|November 17, 2022
Mechanisms of resistance to venetoclaxAdalgisa Condoluci, Davide Rossi
Blood|March 19, 2016
Splenic marginal zone lymphoma: from genetics to managementLuca Arcaini, Davide Rossi, Marco Paulli
Blood|April 26, 2018
Biology and treatment of Richter syndromeDavide Rossi, Valeria Spina, Gianluca Gaidano
Blood|December 25, 2007
Prognostic assessment of BCL2-938C>A polymorphism in chronic lymphocytic leukemiaDavide Rossi, Silvia Rasi, Daniela Capello, et al.
Blood|February 6, 2010
Impact of the host genetic background on prognosis of chronic lymphocytic leukemiaSilvia Rasi, Francesco Forconi, Alessio Bruscaggin, et al.
Blood|April 26, 2003
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphomaGianluca Gaidano, Laura Pasqualucci, Daniela Capello, et al.
Pageof 6